Skip to main content

Table 1 Demographic characteristic and training protocol of the included studies

From: Effects of soft robotic exosuit on ambulation ability in stroke patients: a systematic review

Study

Design

Location

Participants

Type of device

Protocol

Outcome measures (Method)

Follow-up period

Awad et al. (2020) [15]

Non-comparative interventional study

America

N = 36a

Mean age = 57 yrs

Stroke latency = 7.3 yrs

ReWalk ReStore™

soft robotic exosuitb

(Net weight: 5 kg)

5 training sessions in 1 month

(20 min on treadmill and 20 min on ground)

Maximal walking speed (10MWT)

About 1 month

Shin et al (2022) [16]

Non-comparative interventional study

America

N = 5

Mean age = 46 yrs

Stroke latency = 2.7 yrs

ReWalk ReStore™

soft robotic exosuitb

(Net weight: 5 kg)

18 training sessions in 2 months

(30 min on treadmill)

Walking speed (10MWT), walking distance (6MWT and 2MWT), Fugl-Meyer scale

About 2 months

Poydasheva et al. (2016) [17]

Non-comparative interventional study

Russia

N = 14

Median age = 53 yrs

Stroke latency = 1.2 yrs

Regent soft exoskeleton complex

10 training sessions in 2 weeks + Standard stroke rehabilitation

Walking time (10MWT), Fugl-Meyer scale

About 2 weeks

Awad et al (2017) [19]

Exploratory research

America

N = 9

Mean age = 49 yrs

Stroke latency = 4.4 yrs

Soft robotic exosuit

(Net weight: 0.9 kg)

Single-session

Maximal walking speed (10MWT), peak dorsiflexion anglec, peak paretic propulsion, energy cost

Only measure immediate effect

Sloot et al (2022) [20]

Exploratory research

America

N = 8

Mean age = NS

Stroke latency = NS

Soft robotic exosuitb

(Net weight: 2 kg)

Single-session

Walking speed (5-min walking test), peak dorsiflexion angle c, peak paretic propulsion, energy cost

Only measure immediate effect

Awad et al (2017) [18]

Exploratory research

America

N = 8

Mean age = 48 yrs

Stroke latency = 3.2 yrs

Soft robotic exosuit

(Net weight: 0.9 kg)

Single-session

Peak dorsiflexion angle c, hip hiking, hip circumduction, stride length

Only measure immediate effect

Porciuncula et al. (2021) [13]

Case report

America

N = 1

Patient’s age = 54 yrs

Stroke latency = 5.6 yrs

Soft robotic exosuitd

Robotic Exosuit Augmented Locomotion gait training (REAL gait training): 5 training sessions in 5 consecutive days (30 min on treadmill)

Maximal/comfortable walking test (10MWT), walking distance (6MWT), hip hiking, hip circumduction, stride length

About 1 week

Porciuncula et al. (2019) [12]

Case report

America

N = 1

Patient’s age = 58 yrs

Stroke latency = 4.5 yrs

Soft robotic exosuit

6 training sessions(over 2 weeks)

Walking speed (10MWT), walking distance (6MWT), stride length

About 2 weeks

Kwon et al (2019) [14]

Case report

Korea

N = 1

Patient’s age = 49 yrs

Stroke latency = 10 months

Soft wearable robotic ankle–foot-orthosise

(Net weight: 1.54 kg)

Plantarflexion 30–70 N

Dorsiflexion 50 N

Single-session

Walking speed (9-m walking test), walking distance (6MWT), stride length

Only measure immediate effect

  1. N = number, yrs = years, Exp = experimental group, kg = kilogram, 10MWT = 10-m walking test, 6MWT = 6-min walking test, 2MWT = 2-min walking test, N/S = not stated
  2. a Forty-four participants completed safety and reliability evaluation, but only 36 participants completed all training sessions
  3. b Machine provided 25% of the user’s body weight for plantarflexion during push-off and the minimum needed for adequate ground clearance
  4. c Peak ankle dorsiflexion angle during swing phase
  5. d The maximum force was set at 180 N, with onset time at 38–40% of the gait cycle
  6. e Machine provided 30–70 N for plantarflexion and 50 N for dorsiflexion